Literature DB >> 5252232

Treatment of adult acute leukemia with arabinosylcytosine and thioguanine.

T S Gee, K P Yu, B D Clarkson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 5252232     DOI： 10.1002/1097-0142(196905)23:5<1019::aid-cncr2820230506>3.0.co;2-n

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  22 in total

Review 1.  Antineoplastic and immunosuppressive drugs. 3. Adverse effects and therapeutic problems.

Authors:  M D Cridland
Journal:  Drugs       Date:  1972       Impact factor: 9.546

Review 2.  Antineoplastic and immunosuppressive drugs. II. Therapeutic uses.

Authors:  M D Cridland
Journal:  Drugs       Date:  1972       Impact factor: 9.546

Review 3.  Cancer chemotherapy--the first twenty-five years.

Authors:  R B Scott
Journal:  Br Med J       Date:  1970-10-31

4.  [Clinico-pharmacologic, cytochemical and Feulgen photometric studies in adult undifferentiated cell leukemias under combination chemotherapy with vincristine, daunorubicine and prednisone].

Authors:  P Obrecht; H Merker; H H Hennekeuser; G Meuret; M Westerhausen; A Simon
Journal:  Klin Wochenschr       Date:  1970-11-01

5.  The treatment of acute myelocytic leukemia.

Authors:  A R Ablin
Journal:  Calif Med       Date:  1972-12

6.  Treatment of acute myeloid leukaemia according to the Hammersmith protocol: preliminary report.

Authors:  W Paolino; L Resegotti; M Rossi; V Infelise
Journal:  Br Med J       Date:  1973-09-15

7.  Management of adult acute myelogenous leukaemia.

Authors:  D Crowther; R L Powles; C J Bateman; M E Beard; C L Gauci; P F Wrigley; J S Malpas; G H Fairley; R B Scott
Journal:  Br Med J       Date:  1973-01-20

Review 8.  Cancer chemotherapy: new strategies for success.

Authors:  N A Berger
Journal:  J Clin Invest       Date:  1986-11       Impact factor: 14.808

9.  Treatment of acute myeloblastic leukemia in adults: remission induction with a combination of cyclophosphamide, cytarabine and vincristine.

Authors:  H Abu-Zahra; A Clarysse; D H Cowan; R Hasselback; D E Bergsagel
Journal:  Can Med Assoc J       Date:  1972-12-09       Impact factor: 8.262

10.  Therapy of acute myelocytic leukemia. Daunomycin contrasted with a combination of cytosine arabinoside and 6-thioguanine.

Authors:  J L Poth; P K Johnson; R P George; S L Schrier
Journal:  Calif Med       Date:  1972-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.